Effects of Cilostazol on Platelet Activation in Coronary Stenting Patients Who Already Treated with Aspirin and Clopidogrel
Jeong Cheon Ahn, Woo Hyuk Song, Jung Ah Kwon, Chang Gyu Park, Hong Seok Seo, Dong Joo Oh, Young Moo Rho
Korean J Intern Med. 2004;19(4):230-236. Published online 2004 Dec 1 DOI: https://doi.org/10.3904/kjim.2004.19.4.230
Citations to this article as recorded by 
Cilostazol combined with P2Y12 receptor inhibitors: A substitute antiplatelet regimen for aspirin‐intolerant patients undergoing percutaneous coronary stent implantation
Yikai Zhao, Peng Zhou, Wen Gao, Haoxuan Zhong, Yufei Chen, Wei Chen, Maieryemu Waresi, Kun Xie, Haiming Shi, Hui Gong, Guibin He, Zhaohui Qiu, Xinping Luo, Jian Li
Clinical Cardiology.2022; 45(2): 189. CrossRef
Update on Cilostazol: A Critical Review of Its Antithrombotic and Cardiovascular Actions and Its Clinical Applications
Antonis A. Manolis, Theodora A. Manolis, Helen Melita, Dimitri P. Mikhailidis, Antonis S. Manolis
The Journal of Clinical Pharmacology.2022; 62(3): 320. CrossRef
The Safety and Efficacy of Triple Antiplatelet Therapy after Intracranial Stent-Assisted Coil Embolization
Yoshihisa Matsumoto, Minoru Iko, Masanori Tsutsumi, Takahumi Mitsutake, Ayumu Eto, Kouhei Nii, Kanji Nakai, Hiromichi Oishi, Hiroshi Aikawa, Kiyoshi Kazekawa
Journal of Stroke and Cerebrovascular Diseases.2015; 24(7): 1513. CrossRef
Effect of Antiplatelets in Diabetic Peripheral Vasculopathy: Comparison by Ankle-Brachial Index and Peak Wave Velocity
Se-Jin Park
Journal of Korean Foot and Ankle Society.2014; 18(4): 159. CrossRef
Randomized comparison of new dual-antiplatelet therapy (aspirin, prasugrel) and triple-antiplatelet therapy (aspirin, clopidogrel, cilostazol) using P2Y12 point-of-care assay in patients with STEMI undergoing primary PCI
Tae-Hyun Yang, Han-Young Jin, Kyu-Nam Choi, Ungjeong Do, Hyung Jun Kim, Sang-Ryul Chung, Jeong-Sook Seo, Jae-Sik Jang, Dae-Kyeong Kim, Dong-Soo Kim
International Journal of Cardiology.2013; 168(1): 207. CrossRef
The Evolution of Antiplatelet Therapy in the Treatment of Acute Coronary Syndromes
Dominick J. Angiolillo
Drugs.2012; 72(16): 2087. CrossRef
Detection of Clopidogrel Hyporesponsiveness Using a Point-of-Care Assay and the Impact of Additional Cilostazol Administration after Coronary Stent Implantation in Diabetic Patients
Tae-Hyun Yang, Doo-Il Kim, Dong-Kie Kim, Jae-Sik Jang, Ung Kim, Sang-Hoon Seol, Dae-Kyeong Kim, Geu-Ru Hong, Jong-Seon Park, Dong-Gu Shin, Young-Jo Kim, Yun-Kyeong Cho, Chang-Wook Nam, Seung-Ho Hur, Kwon-Bae Kim, Dong-Soo Kim
The Korean Journal of Internal Medicine.2011; 26(2): 145. CrossRef
The clopidogrel resistance can be attenuated with triple antiplatelet therapy in patients undergoing drug-eluting stents implantation
Chi Young Shim, Se-Jung Yoon, Sungha Park, Jung-Sun Kim, Jong Rak Choi, Young-Guk Ko, Donghoon Choi, Jong-Won Ha, Yangsoo Jang, Namsik Chung, Won-Heum Shim, Seung-Yun Cho
International Journal of Cardiology.2009; 134(3): 351. CrossRef
Efficacy of Triple Anti-Platelet Therapy Including Cilostazol in Acute Myocardial Infarction Patients Undergoing Drug-Eluting Stent Implantation
Keun-Ho Park, Myung Ho Jeong, Min Goo Lee, Jum Suk Ko, Shin Eun Lee, Won Yu Kang, Soo Hyun Kim, Doo Sun Sim, Nam Sik Yoon, Hyun Ju Youn, Young Joon Hong, Hyung Wook Park, Ju Han Kim, Youngkeun Ahn, Jeong Gwan Cho, Jong Chun Park, Jung Chaee Kang
Korean Circulation Journal.2009; 39(5): 190. CrossRef
Comparison of Triple Anti-Platelet Therapy (Aspirin, Clopidogrel, and Cilostazol) and Double Anti-Platelet Therapy (Aspirin and Clopidogrel) on Platelet Aggregation in Type 2 Diabetic Patients Undergoing Drug-Eluting Stent Implantation
Tae-Hyun Yang, Doo Il Kim, Jong Yoon Kim, Il Hwan Kim, Ki-Hun Kim, Yang Chun Han, Woong Kim, Sang Hoon Seol, Seong Man Kim, Dae Kyeong Kim, Dong Soo Kim
Korean Circulation Journal.2009; 39(11): 462. CrossRef
Effect of Cilostazol Treatment on Adiponectin and Soluble CD40 Ligand Levels in Diabetic Patients With Peripheral Arterial Occlusion Disease
Ching-Jung Hsieh, Pei-Wen Wang
Circulation Journal.2009; 73(5): 948. CrossRef
Effects of Triple Antiplatelet Therapy (Aspirin, Clopidogrel, and Cilostazol) on Platelet Aggregation and P-Selectin Expression in Patients Undergoing Coronary Artery Stent Implantation
Bong-Ki Lee, Seung-Whan Lee, Seong-Wook Park, Se-Whan Lee, Duk-Woo Park, Young-Hak Kim, Cheol Whan Lee, Myeong-Ki Hong, Jae-Joong Kim, Seongsoo Jang, Hyun-Sook Chi, Seung-Jung Park
The American Journal of Cardiology.2007; 100(4): 610. CrossRef
Gastroduodenal mucosal injury in patients on antiplatelet therapy
Takatsugu Yamamoto, Masaki Sanaka, Kunitaka Nagasawa, Koichiro Abe, Masako Fukami, Shin Nakayama, Akihiko Tsuchiya, Taro Ishii, Yasushi Kuyama
Thrombosis Research.2007; 120(4): 465. CrossRef
Cilostazol Could Ameliorate Platelet Responsiveness to Clopidogrel in Patients Undergoing Primary Percutaneous Coronary Intervention
Jang-Young Kim, Kyounghoon Lee, Myungsang Shin, Minsoo Ahn, Hyunmin Choe, Byung-Su Yoo, Junghan Yoon, Kyung-Hoon Choe, Seung-Hwan Lee
Circulation Journal.2007; 71(12): 1867. CrossRef
Optimal management of platelet function after coronary stenting
Seung-Jung Park, Seung-Whan Lee
Current Treatment Options in Cardiovascular Medicine.2007; 9(1): 37. CrossRef
Cilostazol, a phosphodiesterase 3 inhibitor, protects mice against acute and late ischemic brain injuries
Yi-Lu Ye, Wen-Zhen Shi, Wei-Ping Zhang, Meng-Ling Wang, Yu Zhou, San-Hua Fang, Li-Ying Liu, Qi Zhang, Yue-Ping Yu, Er-Qing Wei
European Journal of Pharmacology.2007; 557(1): 23. CrossRef
Titration with an Initially Lower Dose Increased Compliance of Cilostazol (Pletaal®) in Diabetic Patients
Hyo-Jeong Kim, Kyung Ah Han, Hyun-Jin Kim, Kang-Seo Park, Eung Jin Kim, Kyung Wan Min
The Journal of Korean Diabetes Association.2006; 30(5): 388. CrossRef
Triple Versus Dual Antiplatelet Therapy After Coronary Stenting
Seung-Whan Lee, Seong-Wook Park, Myeong-Ki Hong, Young-Hak Kim, Bong-Ki Lee, Jong-Min Song, Ki Hoon Han, Cheol Whan Lee, Duk-Hyun Kang, Jae-Kwan Song, Jae-Joong Kim, Seung-Jung Park
Journal of the American College of Cardiology.2005; 46(10): 1833. CrossRef